For its third fiscal quarter (ending September 30), AtriCure Inc (NASDAQ: ATRC) has reported a -15% decline in E.P.S. from $-0.20 a year ago to $-0.17 in the current quarter. For the latest four quarters through September 30, E.P.S. were $-0.83 compared to $-0.54 a year ago — an increase of 54%.
Recent Price Action
AtriCure Inc (NASDAQ: ATRC) stock closed at $29.43 on 10/29/24 after a large increase of 2.4%. Moreover, trading volume in this advance was exceptionally high at 222% of normal. Relative to the market the stock has been weak over the last nine months but has risen 3.1% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, ATRC is expected to continue to be Value Creation neutral.
AtriCure has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. AtriCure has a slightly negative Power Rating of 35 and a very low Appreciation Score of 14, and the Lowest Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment